Painreform Stock Today
| PRFX Stock | USD 3.20 0.25 8.47% |
PerformanceWeakest
| Odds Of DistressRisky
|
Painreform is trading at 3.20 as of the 12th of February 2026; that is 8.47 percent increase since the beginning of the trading day. The stock's open price was 2.95. Painreform has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 14th of November 2025 and ending today, the 12th of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of September 2020 | Category Healthcare | Classification Health Care |
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel. The company has 2.01 M outstanding shares of which 194.93 K shares are at this time shorted by private and institutional investors with about 0.68 trading days to cover. More on Painreform
Moving together with Painreform Stock
| 0.75 | EDIT | Editas Medicine Earnings Call This Week | PairCorr |
Moving against Painreform Stock
Painreform Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO CFO | Ilan MBA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPainreform utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Painreform's leverage profile, showing how much of Painreform's resources are funded through borrowing.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Painreform (PRFX) is traded on NASDAQ Exchange in USA and employs 2 people. Painreform is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.87 M. Painreform conducts business under Biotechnology sector and is part of Health Care industry. The entity has 2.01 M outstanding shares of which 194.93 K shares are at this time shorted by private and institutional investors with about 0.68 trading days to cover.
Painreform currently holds about 13.85 M in cash with (12.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.3.
Check Painreform Probability Of Bankruptcy
Ownership AllocationPainreform holds 9.39 pct. of its outstanding shares held by insiders and 2.45 pct. owned by third-party entities.
Check Painreform Ownership Details
Painreform Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Justinvest Llc | 2025-06-30 | 13.7 K | |
| Ubs Group Ag | 2025-06-30 | 6.1 K | |
| Advisor Group Holdings, Inc. | 2025-06-30 | 193 | |
| Sbi Securities Co Ltd | 2025-06-30 | 6.0 | |
| Apollon Wealth Management, Llc | 2025-03-31 | 0.0 | |
| Tower Research Capital Llc | 2025-06-30 | 0.0 | |
| Barclays Plc | 2025-03-31 | 0.0 | |
| Hrt Financial Llc | 2025-03-31 | 0.0 |
Painreform Historical Income Statement
Painreform Stock Against Markets
Painreform Corporate Management
| Sigal Aviel | Chief Officer | Profile | |
| Rita Keynan | Vice Operations | Profile | |
| Eyal Broder | Interim Officer | Profile | |
| MBA MBA | CEO CFO | Profile | |
| Pr Hazum | CTO Director | Profile |
Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.